As of 2024-12-15, the Relative Valuation of Addex Therapeutics Ltd (ADXN.SW) is 0.35 CHF. This relative valuation is based on P/E multiples. With the latest stock price at 0.06 CHF, the upside of Addex Therapeutics Ltd based on Relative Valuation is 486.3%.
The range of the Relative Valuation is 0.28 - 0.88 CHF.
| Range | Selected | |
| Trailing P/E multiples | 9.6x - 30.0x | 10.0x |
| Forward P/E multiples | 12.0x - 28.5x | 14.0x |
| Fair Price | 0.28 - 0.88 | 0.35 |
| Upside | 367.1% - 1367.8% | 486.3% |
| Date | P/E |
| 2024-12-13 | 2.05 |
| 2024-12-12 | 2.05 |
| 2024-12-11 | 2.05 |
| 2024-12-10 | 2.03 |
| 2024-12-09 | 1.99 |
| 2024-12-06 | 1.99 |
| 2024-12-05 | 1.86 |
| 2024-12-04 | 1.81 |
| 2024-12-03 | 2.13 |
| 2024-12-02 | 1.99 |
| 2024-11-29 | 2.11 |
| 2024-11-28 | 2.11 |
| 2024-11-27 | 2.14 |
| 2024-11-26 | 2.05 |
| 2024-11-25 | 1.93 |
| 2024-11-22 | 1.93 |
| 2024-11-21 | 1.92 |
| 2024-11-20 | 2.04 |
| 2024-11-19 | 2.01 |
| 2024-11-18 | 2.11 |
| 2024-11-15 | 2.01 |
| 2024-11-14 | 2.21 |
| 2024-11-13 | 2.11 |
| 2024-11-12 | 2.18 |
| 2024-11-11 | 2.66 |
| 2024-11-08 | 2.90 |
| 2024-11-07 | 2.90 |
| 2024-11-06 | 2.83 |
| 2024-11-05 | 2.73 |
| 2024-11-04 | 2.74 |
| 2024-11-01 | 2.84 |
| 2024-10-31 | 2.71 |
| 2024-10-30 | 2.63 |
| 2024-10-29 | 2.72 |
| 2024-10-28 | 2.68 |
| 2024-10-25 | 2.90 |
| 2024-10-24 | 2.92 |
| 2024-10-23 | 2.84 |
| 2024-10-22 | 2.87 |
| 2024-10-21 | 2.70 |
| 2024-10-18 | 2.53 |
| 2024-10-17 | 2.57 |
| 2024-10-16 | 2.56 |
| 2024-10-15 | 2.56 |
| 2024-10-14 | 2.39 |
| 2024-10-11 | 2.39 |
| 2024-10-10 | 2.50 |
| 2024-10-09 | 2.46 |
| 2024-10-08 | 2.46 |
| 2024-10-07 | 2.39 |